Climate Health Medical

US to pull out from Paris Agreement that limits global warming 

The US, the world’s second-largest greenhouse gas emitter in the world, will withdraw from a global pact to limit global warming.

Read More
Health Medical Pharma

US to withdraw from WHO after an executive order from Donald Trump

The US, the World Health Organization’s top donor, has decided to withdraw from the global health body, accusing it of “mishandling” the Covid-19.

Read More
Health Medical Research

Muscle fat raises heart disease risk, independent of BMI, study finds

HQ Team January 20, 2024:People with fat stored within their muscles, known as intermuscular fat, face a significantly higher risk of serious cardiovascular.

Read More
Health Medical Research

Major headway in depression study: 293 new genetic variants found

HQ Team January 20, 2025: Research has unveiled 293 new gene variants linked to major depressive disorder (MDD), significantly enhancing our understanding of.

Read More
Health Medical Research

Study uncovers mechanism behind Huntington’s disease onset

HQ Team January 19, 2025: A study led by researchers from the Broad Institute, Harvard Medical School, and McLean Hospital has shed light.

Read More
Drugs Health Pharma

AstraZeneca’s medicine to treat a type of breast cancer gets US nod

AstraZeneca Plc.’s antibody-drug conjugate for treating a certain type of breast cancer got approval from the US drug regulator, the company stated.

Read More
Health Medical Research

Common sleep drugs may foil brain’s waste-clearance process

HQ Team January 17, 2025: The commonly prescribed sleep medications, particularly zolpidem, known by its brand name Ambien, may disrupt the brain’s natural.

Read More
Health Medical

Hormonal contraceptives and breast cancer risk in BRCA1 carriers

HQ Team January 17, 2025: A study has found a significant association between the use of hormonal contraceptives and an increased risk of.

Read More
Drugs Health Pharma

US drug regulator rejects Atara Biotherapeutics’ rare cancer therapy

Atara Biotherapeutics’ Ebvallotm therapy, for treating patients with a rare cancer that occurs after stem cell transplantation, got rejected by the US drug.

Read More
Drugs Health Medical

Eli Lilly’s Omvoh gains FDA approval for treating Crohn’s disease

HQ Team The US Food and Drug Administration (FDA) has approved Eli Lilly’s Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active.

Read More